RNAi Therapeutics
Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots
Analysis




The potential therapeutic applications of RNAi were
realized almost immediately after the phenomenon was first described; over the
years, developers have gradually progressed their proprietary drug candidates
with cautious optimism





Roots Analysis is pleased to announce the publication of its recent
study, titled, “RNAi
Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA
and DNA.”





The “RNAi Therapeutics Market (2nd Edition), 2019-2030:
Focus On siRNA, miRNA, shRNA and DNA” report features an extensive study of the
current market landscape and future opportunities associated with RNAi
therapeutics. The study also features a detailed analysis of key drivers and
trends within this evolving market. Amongst other elements, the report includes:





To order this 285+ page report, which features 100+ figures
and 110+ tables, please visit this


https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html





§ A
detailed assessment of the current market landscape of drug developers engaged
in the development of RNAi therapeutics.


§ A
competitiveness analysis of key players engaged in this domain, evaluating
their respective product portfolios, type of RNAi molecule, target therapeutic
areas, company size and year of establishment


§ A
detailed analysis of more than 70 completed, ongoing and planned clinical
studies of RNAi therapeutics.


§ A
detailed analysis of various patents that have been filed / granted related to
RNAi therapeutics, since 2014


§ An
analysis of the partnerships that have been established in this domain, in the
recent past.


§ An
analysis of the investments made at various stages of development in companies
engaged in this domain.


§ An
analysis of the key promotional strategies that have been adopted by developers
of marketed oligonucleotide therapeutics, namely Defitelio®, Exondys® and
Onpattro®.


§ Detailed
profiles of RNAi Therapeutics that are in the late stage clinical development


§
A detailed market forecast, featuring analysis of the current
and projected future opportunity across key market segments (listed below)


Key
Therapeutic Areas



§ Oncological
disorders


§ Infectious
diseases


§ Genetic
disorders


§ Ophthalmic
disorders


§ Hepatic
disorders


§ Respiratory
disorders


Type of RNAi
molecule



§ siRNA


§ miRNA


§ shRNA


§ sshRNA


§ DNA


Route of
administration



§ Subcutaneous


§ Intravenous


§ Intradermal


§ Intravitreal


§ Oral


§ Intramuscular


Key
geographical regions



§ North
America


§ Europe


§ Asia
Pacific and the Rest of the world


Leading
Player



To request a sample copy / brochure of this report, please visit
this
- https://www.rootsanalysis.com/reports/295/request-sample.html





Key
companies covered in the report


§ Quark
Pharmaceuticals


§ Alnylam
Pharmaceuticals


§ Dicerna
Pharmaceuticals


§ Souzhou
Ribo Life Sciences


§ Olix
Pharmaceuticals


§ Sirnaomics


§ Ariz
Precision Medicine


§ Arrowhead
Pharmaceuticals


§ Gradalis


§ Benitec
Biopharma





For
more information please click on the following link:


https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market-2nd-edition-2019-2030/278.html


Other Recent Offerings


1.
Gene Therapy Market (3rd
Edition), 2019-2030


2. Global T-Cell (CAR-T,
TCR and TIL) Therapy Market (4th Edition), 2019-2030



3.
Biopharma
Contract Manufacturing Market (3rd Edition), 2019-2030





About Roots Analysis


Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com





Contact Information


Roots
Analysis Private Limited


Gaurav Chaudhary


+1 (415) 800 3415


ben.johnson@rootsanalysis.com


Facebook - https://www.facebook.com/RootsAnalysis


LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/


Twitter - https://twitter.com/RootsAnalysis